Status:
RECRUITING
Thailand HDV Cohort
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborating Sponsors:
King Chulalongkorn Memorial Hospital
Thai Red Cross AIDS Research Centre
Conditions:
HDV
Eligibility:
All Genders
18+ years
Brief Summary
There is very limited data of HDV in Thailand. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among those with low CD4 cells/count, therefore, HDV bur...
Detailed Description
The prevalence of HDV remains ill-defined, mainly for lack of appropriate testing and screening. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among ...
Eligibility Criteria
Inclusion
- Male or female, aged 18 years and older
- Chronically-infected with HBV, as defined by:
- Positive Hepatitis B surface antigen HBsAg) or HBV DNA result with a subsequent positive HBsAg or HBV DNA result at least 6 months after first positive result
- Provide signed and dated informed consent form.
Exclusion
- Non chronic HBV
Key Trial Info
Start Date :
January 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
3152 Patients enrolled
Trial Details
Trial ID
NCT05350865
Start Date
January 30 2023
End Date
May 1 2025
Last Update
October 2 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
HIV-NAT, Thai Red Cross - AIDS Research Centre
Bangkok, Bangkok, Thailand, 10330
2
King memorial Chulalongkorn hospital
Bangkok, Bangkok, Thailand, 10330
3
Siriraj Hospital, Mahidol University
Bangkok, Bangkok, Thailand
4
Taksin Hospital
Bangkok, Bangkok, Thailand